Chongqing Puroton Biotechnology Group Co., Ltd.

Chongqing Puroton Biotechnology Group Co., Ltd. was established in October 2015. As a provider of comprehensive solutions in the field of genetic medicine, Puroton is committed to the technological innovation of“genetic oncology, human microecology, reproductive genetics, and AI life big data”, with an aim to reduce genetic defects,enhance precision treatment of tumors, andmitigatethe harm of major diseases to humans, and a vision to realize the whole chainofmedical care from detection to diagnosis andultimatelyto treatment in the field of genetic medicine. It is a national comprehensive high-techcompanyintegrating scientific and technologicalR & D, technical services, and productmanufacturing.

Firmly keeping the mission of“Making Molecular Medicine More Accurateand Human Life Healthier”, the companyhascompleted more than 2,000self-developedtechnology projects anddevelopedmore than 100 independent intellectual property rights.It possesseshigh-precision instruments and equipment, including but not limited tonext-generation sequencers, multi-type high-throughput sequencers,andhigh-performance computing servers, andthecapabilitiesofindependentR & D andundertaking ofprojects ofprecise medical clinical genetics.

The company adheres to the idea of “Lifelong Cause with Value”. It has a core research team composed of Chinese and foreign academicians, candidates of the “Talent Programs” and “Distinguished Young Scholars” of the state, and high-end professionals under the “Hundred Talents Program” of the Chinese Academy of Sciences.It has established the “Academician and Expert Workstation”, “Post-doctoral Research Workstation”, and “Chongqing Haizhi Workstation”, forming a strategic cooperation model of “industry-university-research” integration. It is also a leader of the innovative development of genetic technology, which promotes the application of cutting-edge research results in civilian healthcare and intelligent medicine. It won the title of “New High-end Research Institute of Chongqing” and is a key technology company in the sponsorship of the municipal government. The company mainly serves colleges and university, research institutes, independent medicalexamination laboratories, and pharmaceuticalcompanies in China, as well as Chinese medical and healthcare institutions such as hospitals and physical examination centers, companies, and individuals.

The companypromptly responds to the nationalstrategy of industrial upgrade of “Health China and Precise Medical Care” and perseveres with accelerating the commercialization of genetic technology achievements driven by innovation, striving for the vision of “The Pioneer of Genetic Technology, The Guardian of Life and Health”.